Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.67 | N/A |
| PEG Ratio (TTM) | 1.75 | N/A |
| P/S Ratio (TTM) | 0.18 | N/A |
| P/B Ratio (TTM) | 1.22 | N/A |
| P/FCF Ratio (TTM) | 14.43 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.25 | N/A |
| Price to 5YR AVG FCF Ratio | 12.93 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.33% | N/A |
| ROE (TTM) | 8.42% | N/A |
| Net Profit Margin (TTM) | 1.20% | N/A |
| ROIC 5YR AVG | 7.78% | N/A |
Growth (78%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.92% | -1.00% | 0.82% |
| Revenue | 1.32% | 20.27% | 30.07% |
| Net Income | 8.55% | 17.16% | 22.52% |
| Cash Flow | 81.18% | 207.93% | 690.97% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.25 | N/A |
| Quick Ratio (TTM) | 0.77 | N/A |
| D/E Ratio (TTM) | 0.50 | N/A |
| Interest Coverage (TTM) | 4.08 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 2.65 | N/A |
| LTL to 5YR AVG FCF | 3.98 | N/A |
| Shares Outstanding Growth 5YR AVG | 19.18% | N/A |